1. Home
  2. INAB vs BHAT Comparison

INAB vs BHAT Comparison

Compare INAB & BHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INAB
  • BHAT
  • Stock Information
  • Founded
  • INAB 2016
  • BHAT 2010
  • Country
  • INAB United States
  • BHAT China
  • Employees
  • INAB N/A
  • BHAT N/A
  • Industry
  • INAB Biotechnology: Pharmaceutical Preparations
  • BHAT Recreational Games/Products/Toys
  • Sector
  • INAB Health Care
  • BHAT Consumer Discretionary
  • Exchange
  • INAB Nasdaq
  • BHAT Nasdaq
  • Market Cap
  • INAB 18.8M
  • BHAT 18.2M
  • IPO Year
  • INAB 2021
  • BHAT 2019
  • Fundamental
  • Price
  • INAB $0.17
  • BHAT $2.15
  • Analyst Decision
  • INAB Strong Buy
  • BHAT
  • Analyst Count
  • INAB 2
  • BHAT 0
  • Target Price
  • INAB $3.60
  • BHAT N/A
  • AVG Volume (30 Days)
  • INAB 1.1M
  • BHAT 1.7M
  • Earning Date
  • INAB 03-13-2025
  • BHAT 04-29-2025
  • Dividend Yield
  • INAB N/A
  • BHAT N/A
  • EPS Growth
  • INAB N/A
  • BHAT N/A
  • EPS
  • INAB N/A
  • BHAT N/A
  • Revenue
  • INAB N/A
  • BHAT $40,461,026.00
  • Revenue This Year
  • INAB N/A
  • BHAT N/A
  • Revenue Next Year
  • INAB N/A
  • BHAT N/A
  • P/E Ratio
  • INAB N/A
  • BHAT N/A
  • Revenue Growth
  • INAB N/A
  • BHAT N/A
  • 52 Week Low
  • INAB $0.16
  • BHAT $1.65
  • 52 Week High
  • INAB $1.74
  • BHAT $145.00
  • Technical
  • Relative Strength Index (RSI)
  • INAB 27.23
  • BHAT 38.66
  • Support Level
  • INAB $0.16
  • BHAT $1.65
  • Resistance Level
  • INAB $0.25
  • BHAT $3.14
  • Average True Range (ATR)
  • INAB 0.02
  • BHAT 0.56
  • MACD
  • INAB -0.01
  • BHAT 0.05
  • Stochastic Oscillator
  • INAB 9.77
  • BHAT 21.80

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About BHAT Blue Hat Interactive Entertainment Technology

Blue Hat Interactive Entertainment Technology is a producer, developer, and operator of augmented reality (AR) interactive entertainment games and toys in China, including interactive educational materials, mobile games, and toys with mobile game features. The company's products include AR Racer, AR Crazy Bug, AR 3D Magic Box, AR Dinosaur, Talking Tom and Friends Bouncing Bubble, and Immersive Education Classes. The company reports in the following segments: Interactive toys - animation series, Interactive toys - game series, and Mobile games, Information services, and Communication services, out of which the majority of the revenue is generated from the game series. The majority of its revenues are generated in China.

Share on Social Networks: